Back
Outfront Media Vs. Aligos Therapeutics Industry Stock Comparison
Buy
58
OUT
Outfront Media
Last Price:
$18.19
Seasonality Move:
2.15%
Buy
65
ALGS
Aligos Therapeutics
Last Price:
$39.78
Seasonality Move:
7.18%
Buy
58
Outfront Media (OUT)
is a Buy
Is Outfront Media a Buy, Sell or Hold?
-
The current Outfront Media [OUT] share price is $18.18. The Score for OUT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
OUT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
65
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $39.78. The Score for ALGS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
OUT Stock Price Chart
What is Outfront Media's stock price today?
-
The Outfront Media share price today is $18.18Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OUT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $39.78Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight buying pressure.
OUT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 43.88 | Sell |
Chaikin Money Flow: | 3120239 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.27 - 19.25) | Sell |
Bollinger Bands (100): | (16.39 - 18.97) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.35 | Buy |
Relative Strength Index (14 RSI): | 80.7 | Buy |
Chaikin Money Flow: | 139105 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.75 - 33.69) | Buy |
Bollinger Bands (100): | (7.04 - 23.32) | Buy |
OUT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.38 | Sell |
20-day SMA: | 18.81 | Sell |
50-day SMA: | 18.57 | Sell |
200-day SMA: | 16.42 | Buy |
8-day EMA: | 18.28 | Sell |
20-day EMA: | 18.54 | Sell |
50-day EMA: | 18.39 | Sell |
200-day EMA: | 16.68 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.12 | Buy |
20-day SMA: | 29.23 | Buy |
50-day SMA: | 18.61 | Buy |
200-day SMA: | 16.23 | Buy |
8-day EMA: | 34.99 | Buy |
20-day EMA: | 29.85 | Buy |
50-day EMA: | 22.37 | Buy |
200-day EMA: | 17.42 | Buy |
Outfront Media Earnings Growth & OUT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.81 per share, and a decrease next year of $0.34 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Outfront Media Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |